Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ORCHPHARMA | NSE
0.05
0.01%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
24/04/2026
566.85
569.45
573.95
558.05
Orchid Pharma Limited a pharmaceutical company engages in the development manufacture and marketing of active pharmaceutical ingredients bulk actives finished dosage formulations and nutraceuticals in India. Its active pharmaceutical ingredients product portfolio includes oral cephalosporins injectable cephalosporins veterinary products and non-antibiotics. The company's multi-therapeutic presence in anti-infectives anti-inflammatory central nervous system cardiovascular segment nutraceuticals and other oral and sterile products as well as offers new drug discovery systems and pharmaceutical research and development services. It also exports its products to approximately 40 countries internationally. In addition the company provides liaising support to customers in regulatory pharma covigilance testing and release retention of samples service providers and business development. The company was formerly known as Orchid Chemicals & Pharmaceuticals Limited and changed its name to Orchid Pharma Limited in October 2015. Orchid Pharma Limited was incorporated in 1992 and is headquartered in Chennai India. As of March 31 2020 Orchid Pharma Limited operates as a subsidiary of Dhanuka Laboratories Limited.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
38.7%1 month
51.7%3 months
46.0%6 months
41.0%59.92
-
5.93
0.12
0.09
44.84
8.02
-
1.13B
28.86B
302.66M
-
9.84
213.00
33.60
9.92
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
47.90
Range1M
105.90
Range3M
239.80
Rel. volume
0.74
Price X volume
35.50M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Gufic Biosciences Limited | GUFICBIO | Drug Manufacturers-Specialty & Generic | 298.3 | 29.92B | 0.61% | 50.00 | 62.51% |
| Bliss Gvs Pharma Limited | BLISSGVS | Drug Manufacturers-Specialty & Generic | 262.68 | 27.66B | -2.27% | 17.04 | 10.32% |
| Dishman Carbogen Amcis Limited | DCAL | Biotechnology | 169.01 | 26.50B | -3.17% | n/a | 41.09% |
| Unichem Laboratories Limited | UNICHEMLAB | Drug Manufacturers-Specialty & Generic | 372.35 | 26.31B | -3.39% | n/a | 10.48% |
| Alembic Limited | ALEMBICLTD | Drug Manufacturers-Specialty & Generic | 91.42 | 23.56B | -2.15% | 12.29 | 0.42% |
| Morepen Laboratories Limited | MOREPENLAB | Drug Manufacturers-Specialty & Generic | 41.72 | 23.05B | -2.27% | 37.53 | 3.42% |
| Panacea Biotec Limited | PANACEABIO | Biotechnology | 368.55 | 23.00B | 3.38% | n/a | 2.49% |
| Hikal Limited | HIKAL | Drug Manufacturers-Specialty & Generic | 181.1 | 22.33B | -3.22% | 69.03 | 68.84% |
| SOLARA | SOLARA | Drug Manufacturers-Specialty & Generic | 477.5 | 20.69B | -4.24% | n/a | 107.90% |
| Indoco Remedies Limited | INDOCO | Drug Manufacturers-Specialty & Generic | 206.34 | 19.01B | -3.48% | 42.22 | 60.54% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| "SAI SILKS (KALAMANDIR) LIMITED " | KALAMANDIR | Apparel Retail | 105.44 | 15.54B | -1.25% | 28.83 | 43.67% |
| Signpost India Limited | SIGNPOST | Advertising Agencies | 261.58 | 15.33B | -2.64% | 30.54 | 80.30% |
| V2 Retail Limited | V2RETAIL | Apparel Retail | 203.06 | 7.24B | -2.11% | 120.49 | 191.28% |
| Bhagyanagar India Ltd | BHAGYANGR | Copper | 219.34 | 7.09B | 1.49% | 36.36 | 52.08% |
| Madhav Copper Limited | MCL | Copper | 59 | 1.63B | -1.55% | 82.22 | 32.14% |
| Cubex Tubings Limited | CUBEXTUB | Copper | 89.31 | 1.30B | -1.13% | 35.85 | 21.78% |
| Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 75.31 | 839.62M | 0.39% | 50.06 | 4.88% |
| Sagardeep Alloys Limited | SAGARDEEP | Copper | 23.58 | 409.35M | -2.16% | 58.62 | 43.14% |
| Heads UP Ventures Limited | HEADSUP | Apparel Retail | 7.29 | 159.72M | 0.00% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 44.84 | 24.85 | Expensive |
| Ent. to Revenue | 8.02 | 11.40 | Cheaper |
| PE Ratio | 59.92 | 51.36 | Par |
| Price to Book | 5.93 | 6.83 | Par |
| Dividend Yield | - | 0.52 | - |
| Std. Deviation (3M) | 45.97 | 42.17 | Par |
| Debt to Equity | 0.12 | 0.35 | Cheaper |
| Debt to Assets | 0.09 | 0.17 | Cheaper |
| Market Cap | 28.86B | 290.82B | Emerging |